240 related articles for article (PubMed ID: 30412791)
1. Post-translational modifications of Parkinson's disease-related proteins: Phosphorylation, SUMOylation and Ubiquitination.
Junqueira SC; Centeno EGZ; Wilkinson KA; Cimarosti H
Biochim Biophys Acta Mol Basis Dis; 2019 Aug; 1865(8):2001-2007. PubMed ID: 30412791
[TBL] [Abstract][Full Text] [Related]
2. SUMO-regulated mitochondrial function in Parkinson's disease.
Guerra de Souza AC; Prediger RD; Cimarosti H
J Neurochem; 2016 Jun; 137(5):673-86. PubMed ID: 26932327
[TBL] [Abstract][Full Text] [Related]
3. Exploring the Roles of Post-Translational Modifications in the Pathogenesis of Parkinson's Disease Using Synthetic and Semisynthetic Modified α-Synuclein.
Chen H; Zhao YF; Chen YX; Li YM
ACS Chem Neurosci; 2019 Feb; 10(2):910-921. PubMed ID: 30628768
[TBL] [Abstract][Full Text] [Related]
4. Deciphering the Role of Aberrant Protein Post-Translational Modification in the Pathology of Neurodegeneration.
Shafi S; Singh A; Gupta P; Chawla PA; Fayaz F; Sharma A; Pottoo FH
CNS Neurol Disord Drug Targets; 2021; 20(1):54-67. PubMed ID: 32885763
[TBL] [Abstract][Full Text] [Related]
5. Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson's disease pathogenesis and therapies.
Oueslati A; Fournier M; Lashuel HA
Prog Brain Res; 2010; 183():115-45. PubMed ID: 20696318
[TBL] [Abstract][Full Text] [Related]
6. Protein Language: Post-Translational Modifications Talking to Each Other.
Vu LD; Gevaert K; De Smet I
Trends Plant Sci; 2018 Dec; 23(12):1068-1080. PubMed ID: 30279071
[TBL] [Abstract][Full Text] [Related]
7. The three 'P's of mitophagy: PARKIN, PINK1, and post-translational modifications.
Durcan TM; Fon EA
Genes Dev; 2015 May; 29(10):989-99. PubMed ID: 25995186
[TBL] [Abstract][Full Text] [Related]
8. Familial Mutations and Post-translational Modifications of UCH-L1 in Parkinson's Disease and Neurodegenerative Disorders.
Lee YC; Hsu SD
Curr Protein Pept Sci; 2017; 18(7):733-745. PubMed ID: 26899237
[TBL] [Abstract][Full Text] [Related]
9. Progesterone induced Warburg effect in HEK293 cells is associated with post-translational modifications and proteasomal degradation of progesterone receptor membrane component 1.
Sabbir MG
J Steroid Biochem Mol Biol; 2019 Jul; 191():105376. PubMed ID: 31067491
[TBL] [Abstract][Full Text] [Related]
10. Modifications in the cellular proteome and their clinical application.
Elguero B; Gonilski Pacin D; Cárdenas Figueroa C; Fuertes M; Arzt E
Medicina (B Aires); 2019; 79(Spec 6/1):570-575. PubMed ID: 31864228
[TBL] [Abstract][Full Text] [Related]
11. The involvement of post-translational modifications in cardiovascular pathologies: Focus on SUMOylation, neddylation, succinylation, and prenylation.
Gao J; Shao K; Chen X; Li Z; Liu Z; Yu Z; Aung LHH; Wang Y; Li P
J Mol Cell Cardiol; 2020 Jan; 138():49-58. PubMed ID: 31751566
[TBL] [Abstract][Full Text] [Related]
12. Protein purification technique that allows detection of sumoylation and ubiquitination of budding yeast kinetochore proteins Ndc10 and Ndc80.
Ohkuni K; Takahashi Y; Basrai MA
J Vis Exp; 2015 May; (99):e52482. PubMed ID: 25992961
[TBL] [Abstract][Full Text] [Related]
13. Post-translational modification of α-synuclein in Parkinson's disease.
Barrett PJ; Timothy Greenamyre J
Brain Res; 2015 Dec; 1628(Pt B):247-253. PubMed ID: 26080075
[TBL] [Abstract][Full Text] [Related]
14. Histone post-translational modifications in Huntington's and Parkinson's diseases.
Peña-Altamira LE; Polazzi E; Monti B
Curr Pharm Des; 2013; 19(28):5085-92. PubMed ID: 23448464
[TBL] [Abstract][Full Text] [Related]
15. The Role of SUMOylation and Ubiquitination in Brain Ischaemia: Critical Concepts and Clinical Implications.
Bernstock JD; Ye DG; Estevez D; Chagoya G; Wang YC; Gessler F; Hallenbeck JM; Yang W
Curr Issues Mol Biol; 2020; 35():127-144. PubMed ID: 31422937
[TBL] [Abstract][Full Text] [Related]
16. SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination.
Luo HB; Xia YY; Shu XJ; Liu ZC; Feng Y; Liu XH; Yu G; Yin G; Xiong YS; Zeng K; Jiang J; Ye K; Wang XC; Wang JZ
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16586-91. PubMed ID: 25378699
[TBL] [Abstract][Full Text] [Related]
17. Oxidative and nitrative protein modifications in Parkinson's disease.
Danielson SR; Andersen JK
Free Radic Biol Med; 2008 May; 44(10):1787-94. PubMed ID: 18395015
[TBL] [Abstract][Full Text] [Related]
18. Precise protein post-translational modifications modulate ABI5 activity.
Yu F; Wu Y; Xie Q
Trends Plant Sci; 2015 Sep; 20(9):569-75. PubMed ID: 26044742
[TBL] [Abstract][Full Text] [Related]
19. PTMs in conversation: activity and function of deubiquitinating enzymes regulated via post-translational modifications.
Kessler BM; Edelmann MJ
Cell Biochem Biophys; 2011 Jun; 60(1-2):21-38. PubMed ID: 21480003
[TBL] [Abstract][Full Text] [Related]
20. The Involvement of Post-Translational Modifications in Alzheimer's Disease.
Marcelli S; Corbo M; Iannuzzi F; Negri L; Blandini F; Nistico R; Feligioni M
Curr Alzheimer Res; 2018 Feb; 15(4):313-335. PubMed ID: 28474569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
